👑

AbbVie Inc.

ABBVDividend King • 52yrs
Healthcare · Drug Manufacturers - General🇺🇸 United States
$283.54
Dividend Yield2.42%
Annual Dividend$6.92
Ex-Dividend DateJan 15, 2027
Market Cap$501.19B
57/ 100
Financial Health
Caution
⚠ Payout ratio 117% exceeds earningsRevenue growing (10%)52-year dividend King

Automated dividend-safety read-out from payout, leverage, yield, profitability and track record. See the Financials tab for the full per-statement Financial Investigation. Educational only — not investment advice.

At a glance

AbbVie Inc. (ABBV) operates in the Drug Manufacturers - General industry and is based in the United States. It pays a quarterly dividend of $6.92 a year, a yield of 2.42% at the current price of $283.54. AbbVie has raised its dividend for 52 consecutive years, which makes it a Dividend King. Over the last five years the dividend has grown by an average of 6.8% a year. It paid out 117% of its earnings as dividends, more than it earned. 31 analysts cover it; their average 12-month price target of $315.88 is 11.4% above the current price.

Written automatically from the figures on this page, as of Nov 20, 2026. Facts only, not a recommendation.

Price History
Dividend payment dates
Analyst Consensus
Buy
Bullish sentiment
81% of 31 analysts bullish
12-Month Price Target
$315.88
+11.4% vs current price

About AbbVie Inc.

AbbVie Inc. , a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer.

Business description from Yahoo Finance. Verify details in the company's own annual report.

Key Metrics

Valuation

P/E Ratio
48.7
P/B Ratio
N/M
EV/EBITDA
18.0
Beta
0.19
vs S&P 500
52W High
$302.93
52W Low
$190.75

Profitability

Gross Margin
73.72%
Operating Margin
36.63%
Net Margin
15.67%
ROE
—
Free Cash Flow
$17.69B

Financial Health

Debt / Equity
—
total debt ÷ equity; lower is safer
Current Ratio
0.87
>1 healthy
Quick Ratio
0.56
>1 healthy
Employees
57,000
HQ
North Chicago, IL, United States
Data: Yahoo Finance (yfinance)|Updated: Nov 20, 2026 06:18

Data provided by Yahoo Finance via yfinance. Updated daily. Not investment advice.

Legal Disclaimer

This website is not a financial advisor, investment advisor, or financial services provider. We do not offer, recommend, or imply any investment advice of any kind. We do not receive compensation, commissions, or any other benefit from any company, fund, financial product, or third party featured on this site. No content on this website constitutes a recommendation or solicitation to buy, sell, or hold any security or financial instrument.

All financial analysis, ratios, and written commentary are provided for educational and informational purposes only. The Financial Analysis and Financial Investigation sections reflect automated computations applied to publicly available financial data — they do not represent the opinion of a licensed financial professional. Always conduct your own independent research and consult a qualified, regulated financial adviser before making any investment decision. Past performance of dividends, prices, or earnings is not a guarantee of future results.

Data Sources: Yahoo Finance via yfinance (real-time prices, dividend history, financial statements, analyst ratings and price targets) · S&P 500 Dividend Aristocrats Index (official constituent list) · Dividend Kings public records (companies with 50+ years of consecutive dividend increases) · SEC EDGAR company filings (10-K annual reports — primary source for all financial statement data). Data is fetched automatically each day and may be delayed up to 24 hours. All figures are in USD unless otherwise stated.